| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 02/15/2006 | CN1735607A 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030054 6-Hydroxy--2-xanthenone derivatives 9-substituted by a phenyl ring with 1 or 2 substituents for trapping protons, metal ions (Na, Mg, Ca, Zn) or active oxygen species, and which may combine to form a fused ring such as anthracene or benzo-15-crown-5; after trapping compound formed is highly fluorescent |
| 02/08/2006 | CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 02/08/2006 | CN1730479A Aloe dihydro-coumarin and its separation method and uses |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025395 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/01/2006 | CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application |
| 02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
| 02/01/2006 | CN1239472C HIV integrase inhibitors |
| 01/31/2006 | US6992104 C7 carbonate taxane compositions |
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019371 Macrolide analogs |
| 01/26/2006 | US20060019246 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
| 01/25/2006 | EP1617838A1 Composition for oral administration containing alkylene dioxybenzene derivative |
| 01/25/2006 | CN1726206A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 01/24/2006 | US6989455 Supplying to the first hydrogenation zone a maleic acid feedstock, reacting feedstock with hydrogen in presence of hydrogenation catalyst to produce succininc acid, reacting in second zone the product with hydrogen and IInd catalyst |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/19/2006 | WO2006005682A2 Preparation of alpha-hydroxy and alpha-amino ketones |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/12/2006 | WO2006003479A2 New pseudopolymorph of desloratadine formed with carbon dioxide |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/11/2006 | EP1614756A1 A combinatorial polyketide library |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/10/2006 | US6984515 Macrolide analogs |
| 01/05/2006 | WO2006002383A2 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 01/05/2006 | WO2002046150A3 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/04/2006 | EP1611119A1 Pi-3 kinase inhibitor prodrugs |
| 01/04/2006 | EP1610790A2 Anticancer compounds |
| 01/04/2006 | CN1717493A Process for producing macrolide compound |
| 01/04/2006 | CN1717397A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 12/29/2005 | WO2005123725A1 Novel compound having lipase inhibitory activity |
| 12/29/2005 | US20050288364 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/29/2005 | US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 12/28/2005 | EP1609785A1 C-glycoside derivatives and salts thereof |
| 12/28/2005 | EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 12/27/2005 | US6979741 Acetyl-CoA carboxylase inhibitors |
| 12/27/2005 | CA2206799C Small molecule inhibitors of rotamase enzyme activity |
| 12/22/2005 | WO2005121157A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts |
| 12/22/2005 | WO2005121116A1 Chromone derivatives useful as vanilloid antagonists |
| 12/22/2005 | WO2005066151A3 Histone deacetylase inhibitors |
| 12/22/2005 | US20050282862 Aromatic amides |
| 12/22/2005 | US20050282816 Pyrazinylmethyl lactam derivatives |
| 12/22/2005 | CA2569113A1 Chromone derivatives useful as vanilloid antagonists |
| 12/21/2005 | EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 12/21/2005 | EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 12/21/2005 | EP1363897B1 Antagonists of mcp-1 function and methods of use thereof |
| 12/21/2005 | EP1307445B1 Benzofuran derivatives and their use as antibacterial agents |
| 12/21/2005 | CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 12/20/2005 | CA2038025C Optically active alkylenedioxybenzene derivatives and their use in therapy |
| 12/15/2005 | WO2005118777A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 12/15/2005 | WO2005118625A1 Triazole-linked glycoamino acids and glycopeptides |
| 12/15/2005 | WO2005118535A1 Substituted pyrrolidine-2-ones |
| 12/15/2005 | WO2005117837A1 Process for preparation of amorphous form of a drug |
| 12/15/2005 | US20050277772 Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst |
| 12/15/2005 | US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | US20050277631 Vanilloid receptor ligands and their use in treatments |
| 12/15/2005 | DE102004025791A1 Chromanol-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Chromanol derivatives, a process for their preparation and their use as anti-inflammatories |
| 12/15/2005 | CA2568415A1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 12/15/2005 | CA2565689A1 Substituted pyrrolidine-2-ones |
| 12/15/2005 | CA2560984A1 Process for preparation of amorphous form of a drug |
| 12/14/2005 | EP1603901A1 Tetrahydropyran compounds as tachykinin antagonists |
| 12/14/2005 | EP1603896A2 Cxcr3 antagonists |
| 12/14/2005 | EP1603893A1 Ep4 receptor antagonists |
| 12/14/2005 | EP1603887A1 Hiv replication inhibiting pyrimidines and triazines |
| 12/14/2005 | EP1603882A2 Urea and thiourea derivatives |
| 12/14/2005 | EP1603555A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/13/2005 | US6974797 Bactericides for drug resistant bacteria |
| 12/08/2005 | WO2005116015A1 Chromanol derivatives, method for the production thereof, and use thereof as an anti-inflammatory drug |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272785 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 12/08/2005 | US20050272780 Small molecule inhibitors of rotamase enzyme activity |
| 12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272768 Process for preparation of amorphous form of a drug |
| 12/08/2005 | US20050271737 Determination morphology of active material; applying bioactive material as drops to substrate; evaporation |
| 12/07/2005 | EP1602663A1 Triazole-linked glycoamino acids and glycopeptides |
| 12/07/2005 | EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | CN1704406A Intermediate for the preparation of epimino |
| 12/07/2005 | CN1230416C Pharmaceutical compounds |
| 12/06/2005 | CA2331873C Fumagillol derivatives and processes for preparing the same |
| 12/06/2005 | CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes |
| 12/01/2005 | WO2005113535A2 Pyrazinylmethyl lactam derivatives |
| 12/01/2005 | WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |